Menu
Recruiting NCT07608861

Effect of Bilateral Maxillary Block on Intraoperative Remifentanil Consumption

No phase Interventional Septorhinoplasty Remifentanil Consumption Maxillary Block

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Preoperative Maxillary Block, Postoperative Maxillary Block.
Who it may be relevant to
Registry conditions: Septorhinoplasty, Remifentanil Consumption, Maxillary Block. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Bilateral Maxillary Block on Intraoperative Remifentanil Consumption in Septorhinoplasty Surgery

Overview

The maxillary nerve block is a regional anesthetic technique targeting the sensory distribution of the maxillary nerve and is particularly preferred to provide analgesia in midfacial and maxillary surgical procedures. It has been used to optimize perioperative and postoperative pain control, reduce intraoperative opioid requirements, and support hemodynamic stability in procedures including septorhinoplasty, nasal bone osteotomies, nasal valve surgery, and endoscopic sinus surgery. This study aimed to compare the effects of the timing of bilateral maxillary nerve block administration (post-intubation vs. pre-extubation) on intraoperative remifentanil consumption and postoperative analgesia in patients undergoing septorhinoplasty.

Interventions

  • Drug Preoperative Maxillary Block
    After the intubation, the block procedure will be performed under ultrasound guidance using an infrazygomatic approach to access the pterygopalatine fossa. Prior to the procedure, the cheek region will be prepared in accordance with aseptic conditions. A linear ultrasound probe will be positioned over the infrazygomatic area to visualize the maxillary tuberosity, lateral pterygoid plate, coronoid process, and mandibular condyle. The following image optimization using the jaw-opening maneuver, th
  • Drug Postoperative Maxillary Block
    At the end of the surgery, before the extubation, the block procedure will be performed under ultrasound guidance using an infrazygomatic approach to access the pterygopalatine fossa. Prior to the procedure, the cheek region will be prepared in accordance with aseptic conditions. A linear ultrasound probe will be positioned over the infrazygomatic area to visualize the maxillary tuberosity, lateral pterygoid plate, coronoid process, and mandibular condyle. The following image optimization using

Primary outcome measures

  • Intraoperative remifentanil consumption [Time frame: Intraoperative period]
Secondary outcome measures (3)
  • Mean arterial pressure [Time frame: Intraoperative period]
  • Heart rate [Time frame: Intraoperative period]
  • Pain scores [Time frame: First 24 hours after surgery]

Eligibility criteria

Inclusion criteria

  • 18 to 65 years old
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Body mass index 18 to 30 kg/m2
  • Septorhinoplasty surgery

Exclusion criteria

  • Patient refusing the procedure
  • Patients who have previously undergone nasal surgery
  • Chronic opioid or analgesic use
  • Patients with allergies to local anesthetics
  • Patients with Hypertension
  • Patients receiving antihypertensive treatment.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Ankara Etlik City Hospital — Yenimahalle

Identifiers

NCT: NCT07608861 · AEŞH-EK-32

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗